Tyler Technologies, Inc. (TYL) Is At $226.00 Formed Wedge; Orbimed Advisors Has Trimmed By $49.98 Million Its Medtronic Plc (MDT) Stake

Tyler Technologies, Inc. (NYSE:TYL) Logo

Tyler Technologies, Inc. (TYL) formed wedge up with $232.78 target or 3.00% above today’s $226.00 share price. Tyler Technologies, Inc. (TYL) has $8.64 billion valuation. The stock increased 0.18% or $0.41 during the last trading session, reaching $226. About 473,255 shares traded or 94.51% up from the average. Tyler Technologies, Inc. (NYSE:TYL) has risen 35.65% since April 20, 2017 and is uptrending. It has outperformed by 24.10% the S&P500.

Orbimed Advisors Llc decreased Medtronic Plc (MDT) stake by 71.08% reported in 2017Q4 SEC filing. Orbimed Advisors Llc sold 624,800 shares as Medtronic Plc (MDT)’s stock declined 4.15%. The Orbimed Advisors Llc holds 254,200 shares with $20.53M value, down from 879,000 last quarter. Medtronic Plc now has $108.43 billion valuation. The stock decreased 0.24% or $0.19 during the last trading session, reaching $80. About 3.79M shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since April 20, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 82 analyst reports since August 10, 2015 according to SRatingsIntel. Oppenheimer maintained Medtronic plc (NYSE:MDT) on Tuesday, July 18 with “Buy” rating. As per Wednesday, June 1, the company rating was maintained by Wedbush. Needham maintained the stock with “Buy” rating in Friday, August 26 report. The company was maintained on Wednesday, August 23 by Barclays Capital. The company was initiated on Tuesday, September 22 by UBS. The rating was maintained by Oppenheimer with “Buy” on Thursday, March 23. Needham maintained Medtronic plc (NYSE:MDT) on Wednesday, February 21 with “Buy” rating. The stock of Medtronic plc (NYSE:MDT) earned “Equal-Weight” rating by Morgan Stanley on Monday, February 5. Jefferies maintained the stock with “Buy” rating in Wednesday, August 23 report. The rating was maintained by Morgan Stanley on Thursday, March 29 with “Equal-Weight”.

Analysts await Medtronic plc (NYSE:MDT) to report earnings on May, 24. They expect $1.38 earnings per share, up 3.76% or $0.05 from last year’s $1.33 per share. MDT’s profit will be $1.87 billion for 14.49 P/E if the $1.38 EPS becomes a reality. After $1.17 actual earnings per share reported by Medtronic plc for the previous quarter, Wall Street now forecasts 17.95% EPS growth.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.10, from 1.12 in 2017Q3. It dropped, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. Raymond James Tru Na invested 0.16% in Medtronic plc (NYSE:MDT). Vontobel Asset Mngmt holds 3.77 million shares or 2.23% of its portfolio. Baystate Wealth Mgmt Ltd Limited Liability Company owns 663 shares. Hbk Sorce Advisory Ltd Liability, a Pennsylvania-based fund reported 5,312 shares. America First Invest Advisors Ltd Company holds 795 shares. Bokf Na has invested 0.12% in Medtronic plc (NYSE:MDT). Buckingham Cap Management Inc has invested 0.27% in Medtronic plc (NYSE:MDT). 2,607 are owned by Mitchell Cap. Parthenon Limited Liability Corporation has invested 1.61% of its portfolio in Medtronic plc (NYSE:MDT). Mcf Advsr Ltd holds 135 shares or 0% of its portfolio. 11,112 were reported by Peapack Gladstone Financial Corporation. Trust Comm Of Oklahoma accumulated 26,830 shares or 1.04% of the stock. Glob Endowment Mngmt Ltd Partnership holds 43,600 shares or 0.51% of its portfolio. 68,926 were reported by Stonebridge Cap Advsr Llc. Commonwealth Bank & Trust Of Australia reported 0% stake.

Orbimed Advisors Llc increased Dbv Technologies S A stake by 65,600 shares to 578,500 valued at $14.23 million in 2017Q4. It also upped Radius Health Inc (NASDAQ:RDUS) stake by 248,900 shares and now owns 1.37 million shares. Seres Therapeutics Inc was raised too.

Since October 30, 2017, it had 0 insider buys, and 20 selling transactions for $61.62 million activity. The insider WOMBLE DUSTIN R sold 20,000 shares worth $4.22M. LEINWEBER LARRY D had sold 50,000 shares worth $8.87M on Monday, October 30. $1.11 million worth of Tyler Technologies, Inc. (NYSE:TYL) was sold by MOORE H LYNN JR on Friday, December 8. $4.73 million worth of Tyler Technologies, Inc. (NYSE:TYL) was sold by King Luther Jr on Thursday, March 1. The insider Carter Glenn A sold 1,000 shares worth $210,990. On Tuesday, March 6 the insider MILLER BRIAN K sold $1.05M. The insider BRATTAIN DONALD R sold $1.36M.

Investors sentiment decreased to 1.03 in Q4 2017. Its down 0.38, from 1.41 in 2017Q3. It turned negative, as 18 investors sold Tyler Technologies, Inc. shares while 97 reduced holdings. 42 funds opened positions while 76 raised stakes. 34.35 million shares or 1.37% more from 33.89 million shares in 2017Q3 were reported. Ftb Advsr Inc, Tennessee-based fund reported 509 shares. Glenmede Tru Na holds 0% or 150 shares in its portfolio. Fmr Ltd reported 278,248 shares or 0.01% of all its holdings. New York-based Fred Alger Inc has invested 0.15% in Tyler Technologies, Inc. (NYSE:TYL). Brinker Cap owns 6,144 shares. Utah Retirement has invested 0.02% in Tyler Technologies, Inc. (NYSE:TYL). 11 are held by Earnest Partners. Morgan Stanley invested 0% in Tyler Technologies, Inc. (NYSE:TYL). State Of Wisconsin Invest Board accumulated 7,066 shares. Conestoga Capital Ltd Liability has 189,538 shares for 1.29% of their portfolio. Lpl Financial Ltd, California-based fund reported 4,106 shares. 411,882 are owned by Wasatch. Thompson Siegel And Walmsley Limited Liability Com invested in 288 shares. Swiss Comml Bank holds 0.01% or 60,358 shares. Mackenzie Corp stated it has 285,753 shares.

Among 15 analysts covering Tyler Technologies (NYSE:TYL), 11 have Buy rating, 0 Sell and 4 Hold. Therefore 73% are positive. Tyler Technologies had 49 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Maxim Group with “Buy” on Thursday, October 22. Needham maintained Tyler Technologies, Inc. (NYSE:TYL) on Friday, February 19 with “Buy” rating. The company was maintained on Thursday, October 5 by KeyBanc Capital Markets. The firm has “Buy” rating given on Thursday, February 9 by Maxim Group. The stock of Tyler Technologies, Inc. (NYSE:TYL) earned “Buy” rating by Robert W. Baird on Tuesday, March 13. The firm earned “Buy” rating on Monday, July 17 by Maxim Group. The firm has “Buy” rating by Evercore given on Monday, June 27. On Thursday, October 22 the stock rating was maintained by Northland Capital with “Outperform”. On Thursday, April 19 the stock rating was maintained by Benchmark with “Buy”. Piper Jaffray maintained it with “Buy” rating and $200.0 target in Thursday, October 26 report.

Tyler Technologies, Inc. (NYSE:TYL) Institutional Positions Chart